In 2018, we realized that to meet the demand from medical device players who wanted us to work on innovation technology and new neurotechnology. And so we started raising capital. I brought on board some excellent partners in Remind Christian Agamires. So how much have you raised to this point? Certainly we invested around 20, $25 million of our own profits, but in terms of external capital, we will now have raised in excess of $75 million.
The Sunday Times’ tech correspondent Danny Fortson brings on Marcus Gerhardt, chief executive of Blackrock Neurotech, to talk about his boarding school days in Wales (4:00), his dotcom adventures (10:00), pivoting to brain-computer interfaces (16:00), the “Utah array” (18:40), how in 2006 the first person sent an email with his thoughts (20:30), starting the company (23:00), the state of the technology today (26:40), targeting tetraplegics (33:00), getting investment (38:15), going to market (41:30), and reaching an inflection point (47:40).
Hosted on Acast. See acast.com/privacy for more information.